Mill Capital Management’s Elevance Health ELV Stock Holding History

Mill Capital Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.88M	Sell	10,043 -99	-1%	-$36.7K	0.26%	45
2026 Q1	$2.97M	Hold	10,142	–	–	0.23%	48
2025 Q4	$3.56M	Hold	10,142	–	–	0.26%	46
2025 Q3	$3.28M	Hold	10,142	–	–	0.24%	46
2025 Q2	$3.94M	Hold	10,142	–	–	0.31%	42
2025 Q1	$4.41M	Sell	10,142 -91	-0.9%	-$36.5K	0.35%	40
2024 Q4	$3.77M	Sell	10,233 -175	-2%	-$73.2K	0.3%	41
2024 Q3	$5.41M	Sell	10,408 -50	-0.5%	-$26.7K	0.42%	38
2024 Q2	$5.67M	Hold	10,458	–	–	0.47%	37
2024 Q1	$5.42M	Hold	10,458	–	–	0.45%	39
2023 Q4	$4.93M	Hold	10,458	–	–	0.44%	40
2023 Q3	$4.55M	Sell	10,458 -10	-0.1%	-$4.54K	0.45%	41
2023 Q2	$4.65M	Hold	10,468	–	–	0.44%	40
2023 Q1	$4.81M	Hold	10,468	–	–	0.49%	39
2022 Q4	$5.37M	Sell	10,468 -20	-0.2%	-$10.2K	0.59%	38
2022 Q3	$4.76M	Buy	10,488 +10	+0.1%	+$4.79K	0.56%	39
2022 Q2	$5.06M	Hold	10,478	–	–	0.56%	39
2022 Q1	$5.15M	Hold	10,478	–	–	0.49%	38
2021 Q4	$4.86M	Buy	+10,478	New	+$4.41M	0.5%	40

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Mill Capital Management's ELV Position: Q2 2026 in Review

Mill Capital Management reduced its Elevance Health (ELV) stake by 0.98% in Q2 2026, selling an estimated $36.7K and leaving 10,043 shares worth $3.88M. The position accounts for 0.26% of the portfolio, ranked #45.

Mill Capital Management first reported a position in ELV in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.67M in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Mill Capital Management held 10,043 shares of Elevance Health worth $3.88M as of Q2 2026.
Mill Capital Management sold 99 Elevance Health shares in Q2 2026, an estimated $36.7K.
Elevance Health made up 0.26% of Mill Capital Management's portfolio in Q2 2026, its #45 holding.
Mill Capital Management first reported a position in Elevance Health in Q4 2021 and has held it in 19 quarters since.
Mill Capital Management's Elevance Health position peaked at $5.67M in Q2 2024.
1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mill Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.